Bruschi F, Tardelli M, Herac M, Claudel T, Trauner M. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH. Liver Int. 2020;40:1098-1110 pubmed publisher

Armengol S, Arretxe E, Enzunza L, Llorente I, Mendibil U, Navarro Imaz H, et al. SREBP-2-driven transcriptional activation of human SND1 oncogene. Oncotarget. 2017;8:108181-108194 pubmed publisher

Dey P, Baddour J, Muller F, Wu C, Wang H, Liao W, et al. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. 2017;542:119-123 pubmed publisher

Yang L, Li P, Yang W, Ruan X, Kiesewetter K, Zhu J, et al. Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. Cell Metab. 2016;24:627-639 pubmed publisher

Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, et al. Peroxisome proliferator-activated receptor ? activation induces hepatic steatosis, suggesting an adverse effect. PLoS ONE. 2014;9:e99245 pubmed publisher

Kim J, Spiegelman B. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996;10:1096-107 pubmed